Opportunistic infections in patients with pulmonary alveolar proteinosis

被引:90
|
作者
Punatar, Ankit D. [2 ]
Kusne, Shimon [1 ]
Blair, Janis E. [1 ]
Seville, M. Teresa [1 ]
Vikram, Holenarasipur R. [1 ]
机构
[1] Mayo Clin, Div Infect Dis, Phoenix, AZ 85054 USA
[2] Mayo Clin Phoenix, Dept Internal Med, Phoenix, AZ USA
关键词
Pulmonary alveolar proteinosis; Nocardia; Mycobacteria; Fungal; Infection; COLONY-STIMULATING FACTOR; AVIUM-INTRACELLULARE INFECTION; BRONCHOPULMONARY LAVAGE; NOCARDIA-ASTEROIDES; ASSOCIATION; TUBERCULOSIS; ABSCESS; SULFAMETHOXAZOLE; CRYPTOCOCCOSIS; HISTOPLASMOSIS;
D O I
10.1016/j.jinf.2012.03.020
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To describe the demographics, clinical manifestations, treatment, and outcomes of patients with pulmonary alveolar proteinosis (PAP) who developed an opportunistic infection with Nocardia spp., mycobacteria or fungal pathogens. Methods: A case of PAP and Nocardia spp. brain abscess is described. A comprehensive review of the English-language literature was conducted to identify all reported cases of PAP and opportunistic infections between 1950 and July, 2010. Results: Seventy five cases were reviewed. Thirty two patients (43%) had nocardial infection, 28 (37%) mycobacterial infection, and 15 (20%) fungal infection. Thirty nine patients (65%) were male. Seventeen patients (23%) were immunosuppressed. Twenty patients (27%) were active smokers. PAP was the initial diagnosis in 19 patients (33%), while infection presented first in 23 patients (40%); 16 patients (27%) had a concurrent diagnosis of PAP and infection. The average interval between PAP diagnosis and an opportunistic infection was 16 months. Lungs were the most common site of infection; extra-pulmonary infection was present in 27 patients (32%). Thirty nine patients (57%) survived through the follow-up period, while 31 died. Conclusions: Opportunistic infections can either precede or follow a diagnosis of PAP. PAP should be considered in apparently immunocompetent patients who present with an opportunistic infection and diffuse alveolar infiltrates. (C) 2012 Published by Elsevier Ltd on behalf of The British Infection Association.
引用
收藏
页码:173 / 179
页数:7
相关论文
共 50 条
  • [31] Pulmonary alveolar proteinosis
    Trapnell, Bruce C.
    Nakata, Koh
    Bonella, Francesco
    Campo, Ilaria
    Griese, Matthias
    Hamilton, John
    Wang, Tisha
    Morgan, Cliff
    Cottin, Vincent
    McCarthy, Cormac
    NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
  • [32] Pulmonary alveolar proteinosis
    Spock, A
    PEDIATRICS, 1997, 99 (05) : 756 - 756
  • [33] Pulmonary alveolar Proteinosis
    Schabel, C.
    Hetzel, J.
    Joanoviciu, S. D.
    Horger, M.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2012, 184 (04): : 287 - 289
  • [34] PULMONARY ALVEOLAR PROTEINOSIS
    ROSEN, SH
    CASTLEMAN, B
    LIEBOW, AA
    ENZINGER, FM
    HUNT, RTN
    NEW ENGLAND JOURNAL OF MEDICINE, 1958, 258 (23): : 1123 - 1142
  • [35] Pulmonary Alveolar Proteinosis
    Wen-Tian Li
    Wei Liu
    Indian Journal of Surgery, 2023, 85 : 193 - 194
  • [36] PULMONARY ALVEOLAR PROTEINOSIS
    不详
    BMJ-BRITISH MEDICAL JOURNAL, 1958, 2 (AUG9): : 376 - 377
  • [37] PULMONARY ALVEOLAR PROTEINOSIS
    不详
    LANCET, 1958, 2 (JUL19): : 136 - 136
  • [38] ARE AIDS PATIENTS AT RISK FOR PULMONARY ALVEOLAR PROTEINOSIS
    ISRAEL, RH
    MAGNUSSEN, CR
    CHEST, 1989, 96 (03) : 641 - 642
  • [39] ISOLATION OF MYCOBACTERIA IN PATIENTS WITH PULMONARY ALVEOLAR PROTEINOSIS
    WITTY, LA
    TAPSON, VF
    PIANTADOSI, CA
    MEDICINE, 1994, 73 (02) : 103 - 109
  • [40] THERAPEUTIC LAVAGE IN PATIENTS WITH ALVEOLAR PULMONARY PROTEINOSIS
    FILIPPOV, VP
    LEBEDEV, KM
    SAIDOVA, OK
    LOVACHEVA, OV
    TERAPEVTICHESKII ARKHIV, 1984, 56 (11) : 126 - &